NY Attorney General Eric Schneiderman announced a record $181 million settlement with Janssen Pharmaceuticals and its parent company Johnson & Johnson to resolve charges of improper marketing and ...

“Because ‘[w]hat matters is the objective reach of the claim,’…the district court erred to the extent it effectively defined its obviousness inquiry as one concerning the ‘generalized’ suitability of ...

Yes, even a phase III protocol for a “failed” trial can constitute prior art, the U.S. Court of Appeals for the Federal Circuit told a lower court April 1 when it returned Janssen Pharmaceuticals Inc.

Janssen announces results of pan-European research which shows that a third of psychiatrists (34%) delay conversations about the full range of treatment options with their patients living with ...